---
title: "TEM.US (TEM.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TEM.US/news.md"
symbol: "TEM.US"
name: "TEM.US"
parent: "https://longbridge.com/en/quote/TEM.US.md"
datetime: "2026-05-20T02:47:43.238Z"
locales:
  - [en](https://longbridge.com/en/quote/TEM.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TEM.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TEM.US/news.md)
---

# TEM.US (TEM.US) — Related News

### [How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here](https://longbridge.com/en/news/286786866.md)
*2026-05-18T14:23:22.000Z*
> How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here

### [Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts](https://longbridge.com/en/news/286453944.md)
*2026-05-14T18:23:23.000Z*
> Tempus AI Inc. and Bristol Myers Squibb Co. have announced a collaboration to enhance clinical trial design using AI and

### [Cathie Wood, Ross Gerber Snap Up The Same 10 Stocks — Here's The Unlikely Portfolio Crossover](https://longbridge.com/en/news/286304664.md)
*2026-05-13T18:41:16.000Z*
> Cathie Wood and Ross Gerber, prominent investors, share a portfolio of 10 common stocks across their ETFs. Key holdings 

### [Tempus AI Prices $460 Million 0% Convertible Notes Due 2032, Retires Senior Credit Facility](https://longbridge.com/en/news/286239704.md)
*2026-05-13T10:13:00.000Z*
> Tempus AI has completed a $460 million private offering of 0% Convertible Senior Notes due 2032, generating approximatel

### [If AI Reshapes Healthcare, These Three Stocks Could Lead](https://longbridge.com/en/news/286003292.md)
*2026-05-11T22:11:00.000Z*
> The article discusses three stocks poised to benefit from AI in healthcare: Pfizer, Tempus AI, and Medtronic. Pfizer, wi

### [Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB](https://longbridge.com/en/news/285932014.md)
*2026-05-11T11:21:18.000Z*
> Cathie Wood's ARK Invest ETFs adjusted their portfolio by increasing investments in AI infrastructure, genomic medicine,

### [Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”](https://longbridge.com/en/news/285923111.md)
*2026-05-11T10:00:00.000Z*
> Ambry Genetics’ CARE Program has won the 2026 MedTech Breakthrough Award for "Best Overall Health Informatics Solution."

### [BTIG Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM)](https://longbridge.com/en/news/285843315.md)
*2026-05-10T13:38:41.000Z*
> BTIG analyst Mark Massaro has maintained a Buy rating for Tempus AI, Inc. Class A (TEM) with a price target of $80.00, w

### [3 Stocks Poised to Disrupt the Healthcare Market by 2030](https://longbridge.com/en/news/285719882.md)
*2026-05-08T12:00:19.000Z*
> Three companies are set to disrupt the healthcare market by 2030: Tempus AI, Recursion Pharmaceuticals, and Axsome Thera